Brind.
  1. Infosys is facing selling pressure in the IT sector while also being highlighted as a top performer in the Nifty Midsmall Healthcare sector.

Citi maintained a buy rating on Max Healthcare stock.

1 report, 1 independent Updated Jun 18
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Citi maintained a buy rating on Max Healthcare stock.

Who's involved

What this event is mainly about
Max Healthcare

Keep exploring

Part of

Infosys is facing selling pressure in the IT sector while also being highlighted as a top performer in the Nifty Midsmall Healthcare sector. All 1 developments

The entities involved

Coverage

Newest first; wire copies grouped